ロード中...

Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer

Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...

詳細記述

保存先:
書誌詳細
主要な著者: Matthew G. Field, H. Culver Boldt, Taher Abu Hejleh, Elaine M. Binkley
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2022-06-01
シリーズ:American Journal of Ophthalmology Case Reports
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S2451993622002055
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!